Psychedelic Business Spotlight: November 5
Business, Stock Reports
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
Thanks for an honest and we’ll measured article on this topic. This topic absolutely needs more public discourse.
Would like to know about upcoming trials regarding Psychedelics! the ones already completed really don’t help me with anything. this is very important for me to get on one of these clinical trials around Boston.
“abstinent from the demon-drink”
C’mon. Really?
I would love to get into a trail Ketarx for Parkinsons and Psilocybin for the associated anxiety and depression. Can anyone show me the way to relief?